- call +1-201-465-4211
- email sales@mrinsights.biz
Screening means checking your body for cancer before you have symptoms.
Scope of the Report:
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
The global Cancer Testing/Screening market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Testing/Screening.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Cancer Testing/Screening market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Testing/Screening market by product type and applications/end industries.
Market Segment by Companies, this report covers
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
Market Segment by Applications, can be divided into
Hospitals and Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cancer Testing/Screening Market Overview
1.1 Product Overview and Scope of Cancer Testing/Screening
1.2 Classification of Cancer Testing/Screening by Types
1.2.1 Global Cancer Testing/Screening Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Testing/Screening Revenue Market Share by Types in 2017
1.2.3 Lung Cancer
1.2.4 Blood Cancer
1.2.5 Bone Cancer
1.2.6 Gall Bladder Cancer
1.2.7 Others
1.3 Global Cancer Testing/Screening Market by Application
1.3.1 Global Cancer Testing/Screening Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Cancer Testing/Screening Market by Regions
1.4.1 Global Cancer Testing/Screening Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Testing/Screening Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Testing/Screening Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Testing/Screening Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Testing/Screening Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Testing/Screening Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Testing/Screening (2013-2023)
2 Manufacturers Profiles
2.1 Dias Orin
2.1.1 Business Overview
2.1.2 Cancer Testing/Screening Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dias Orin Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.2 Epigenetics
2.2.1 Business Overview
2.2.2 Cancer Testing/Screening Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Epigenetics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.3 Techlab
2.3.1 Business Overview
2.3.2 Cancer Testing/Screening Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Techlab Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.4 Positive Bioscience
2.4.1 Business Overview
2.4.2 Cancer Testing/Screening Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Positive Bioscience Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genextropy
2.5.1 Business Overview
2.5.2 Cancer Testing/Screening Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genextropy Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.6 M Genomics
2.6.1 Business Overview
2.6.2 Cancer Testing/Screening Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 M Genomics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.7 20/20 GeneSystems
2.7.1 Business Overview
2.7.2 Cancer Testing/Screening Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 20/20 GeneSystems Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.8 AB SCIEX
2.8.1 Business Overview
2.8.2 Cancer Testing/Screening Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AB SCIEX Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
2.9 Abbott Laboratories
2.9.1 Business Overview
2.9.2 Cancer Testing/Screening Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Abbott Laboratories Cancer Testing/Screening Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Testing/Screening Market Competition, by Players
3.1 Global Cancer Testing/Screening Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Testing/Screening Players Market Share
3.2.2 Top 10 Cancer Testing/Screening Players Market Share
3.3 Market Competition Trend
4 Global Cancer Testing/Screening Market Size by Regions
4.1 Global Cancer Testing/Screening Revenue and Market Share by Regions
4.2 North America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
5 North America Cancer Testing/Screening Revenue by Countries
5.1 North America Cancer Testing/Screening Revenue by Countries (2013-2018)
5.2 USA Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6 Europe Cancer Testing/Screening Revenue by Countries
6.1 Europe Cancer Testing/Screening Revenue by Countries (2013-2018)
6.2 Germany Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.4 France Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Testing/Screening Revenue by Countries
7.1 Asia-Pacific Cancer Testing/Screening Revenue by Countries (2013-2018)
7.2 China Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.5 India Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
8 South America Cancer Testing/Screening Revenue by Countries
8.1 South America Cancer Testing/Screening Revenue by Countries (2013-2018)
8.2 Brazil Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Testing/Screening by Countries
9.1 Middle East and Africa Cancer Testing/Screening Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Testing/Screening Revenue and Growth Rate (2013-2018)
10 Global Cancer Testing/Screening Market Segment by Type
10.1 Global Cancer Testing/Screening Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Testing/Screening Market Forecast by Type (2018-2023)
10.3 Lung Cancer Revenue Growth Rate (2013-2023)
10.4 Blood Cancer Revenue Growth Rate (2013-2023)
10.5 Bone Cancer Revenue Growth Rate (2013-2023)
10.6 Gall Bladder Cancer Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Cancer Testing/Screening Market Segment by Application
11.1 Global Cancer Testing/Screening Revenue Market Share by Application (2013-2018)
11.2 Cancer Testing/Screening Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)
12 Global Cancer Testing/Screening Market Size Forecast (2018-2023)
12.1 Global Cancer Testing/Screening Market Size Forecast (2018-2023)
12.2 Global Cancer Testing/Screening Market Forecast by Regions (2018-2023)
12.3 North America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.6 South America Cancer Testing/Screening Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Testing/Screening Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cancer Testing/Screening Picture
Table Product Specifications of Cancer Testing/Screening
Table Global Cancer Testing/Screening and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
